Outcomes associated with antiphospholipid antibodies in COVID-19: A prospective cohort study

ЕЛ Насонов - Научно-практическая ревматология, 2023 - cyberleninka.ru

В спектре механизмов хронического воспаления центральное место занимают два
фундаментальных патологических процесса-аутоиммунитет и аутовоспаление …

被引用次数：16 相关文章所有 3 个版本

Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic

T Zekić, A Belančić - Rheumatology International, 2024 - Springer

Thrombosis is one of the many signs of antiphospholipid syndrome (APS) and COVID-19
infection. Although the mechanisms contributing to thrombosis in APS and COVID-19 are …

Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching

S Oba, T Hosoya, R Kaneshige, D Kawata… - Frontiers in …, 2023 - frontiersin.org

Background Thrombosis is a unique complication of coronavirus disease 2019 (COVID-19).
Although antiphospholipid antibodies (aPL) are detected in COVID-19 patients, their clinical …

被引用次数：2 相关文章所有 5 个版本

[PDF] mediar-press.net

Пандемия коронавирусной болезни 2019 (COVID-19) и аутоиммунные ревматические заболевания: итоги и перспективы

ЕЛ Насонов - Научно-практическая ревматология, 2024 - rsp.mediar-press.net

Аннотация Пандемия коронавирусной болезни 2019 (COVID-19, coronavirus disease
2019), этиологически связанной с вирусом SARS-CoV-2 (severe acute respiratory …

被引用次数：2 相关文章

Evaluation of hypercoagulable states and molecular markers of acute venous thrombosis

I Minga, AJ Tafur, JA Caprini - Handbook of Venous and …, 2024 - taylorfrancis.com

Vessel injury, venous stasis, and accelerated coagulability disrupt the necessary hemostasis
needed for the balance between clot formation and clot dissolution. These three factors …